Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles

NCT03400202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2019-01-23

No results posted yet for this study

Summary

This study will evaluate the physiopathologic characteristics of dark circles in participants with various ethnicities and Fitzpatrick Skin Types and the impact of the dark circles on the quality of life.

Conditions

  • Periorbital Hyperpigmentation

Interventions

DEVICE

Skin imaging

Non-invasive in vivo skin imaging will be taken with the VivoSight Ox Optical Coherence Tomography (OCT).

OTHER

Facial cleanser

Facial cleanser prior to procedures.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Lisa Goberdhan · Allergan

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-02
Primary Completion
2018-11-07
Completion
2018-11-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03400202 on ClinicalTrials.gov